A kidney drug, finerenone, may be beneficial for millions more patients than previously thought. Three major studies have reportedly shown the drug's expanded benefits, potentially protecting the kidneys and heart of a larger population. The exact number of patients who could benefit is unclear, with some outlets suggesting it could be in the hundreds of millions.